Oblique Therapeutics Company

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Founded Date: 2015
Last Funding Type: Pre-Seed
Headquarters: G˜РЄ њРЎteborg, Vastra Gotaland, Sweden
Technology: Anti-infective Drugs
Employee Number: 1-10
Industry: PharmTech
Estimated Revenue: Less than $1M
Total Funding: €130K